Please assess the completion status of the following clinical trial:

Trial Title: Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Histopathologic confirmation of malignant pleural mesothelioma~* Patients who are able to tolerate surgical cytoreduction but unable to undergo extrapleural pneumonectomy due to poor cardiopulmonary reserve or tumor invasion or those with minimal disease~* Male on non-pregnant female~* 18 years of age or older~* No evidence of spread outside the ipsilateral hemithorax by chest CT and chest MRI~* Ejection fraction \> 45%~* Pre-operative WBC \> 4K/uL~* Estimated life expectancy of at least 12 weeks~* Evidence of adequate renal and hepatic function~* Grossly normal contralateral pulmonary function with a chest radiograph and chest CT scan~* Karnofsky performance status of 70% or greater~* No evidence of disease progression by chest CT or chest MRI, obtained at 8 weeks following surgery~Exclusion Criteria:~* Extended disease outside the ipsilateral hemithorax as determined on pre-operative radiographs or intraoperative findings~* Positive extrapleural nodes as determined by mediastinoscopy~* Gross disease (estimated thickness \> 10mm at any intrathoracic location) present within the hemithorax after surgery~* Evidence of distant metastatic disease~* Severe non-malignant co-morbid disease, uncontrolled angina, myocardial infarction on the past 6 months, renal insufficiency, liver disease, pulmonary hypertension~* Pregnant or breast-feeding~* Serious concomitant systemic disorders~* Presence of active concomitant malignancy~* Psychiatric or addictive disorders, which would preclude informed consent~* Previous chemotherapy or radiation therapy for mesothelioma~* Chemotherapy or radiation therapy administered within 3 years for another malignancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Surgery+Heated Cisplatin+Sodium Thiosulfate+Adjuvant CT (Type: EXPERIMENTAL): Participants undergo surgery, Pleurectomy/Decortication, followed by heated cisplatin given as a one-hour lavage of the chest and abdominal cavity then sodium thiosulfate given intravenously over 6 hours. The adjuvant chemotherapy regimen beginning 6-10 weeks after surgery is a combination of cisplatin and Alimta each given day 1 of a 21-day cycle for 3 cycles.

Based on this trial design, predict the completion outcome and termination type (if applicable).